Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland.
Eur J Pharm Biopharm. 2013 Sep;85(1):119-29. doi: 10.1016/j.ejpb.2013.02.011.
Implant design for bone regeneration is expected to be optimized when implant structures resemble the anatomical situation of the defect site. We tested the validity of this hypothesis by exploring the feasibility of generating different in vitro engineered bone-like structures originating from porous silk fibroin scaffolds decorated with RGD sequences (SF-RGD), seeded with human mesenchymal stem cells (hMSC). Scaffolds with small (106-212 μm), medium (212-300 μm), and large pore diameter ranges (300-425 μm) were seeded with hMSC and subsequently differentiated in vitro into bone-like tissue resembling initial scaffold geometries and featuring bone-like structures. Eight weeks after implantation into calvarial defects in mice, the in vitro engineered bone-like tissues had remodeled into bone featuring different proportions of woven/lamellar bone bridging the defects. Regardless of pore diameter, all implants integrated well, vascularization was advanced, and bone marrow ingrowth had started. Ultimately, in this defect model, the geometry of the in vitro generated tissue-engineered bone structure, trabecular- or plate-like, had no significant impact on the healing of the defect, owing to an efficient remodeling of its structure after implantation.
当植入物结构类似于缺损部位的解剖情况时,预计骨再生的植入物设计将得到优化。我们通过探索从具有 RGD 序列(SF-RGD)的多孔丝素支架生成不同体外工程骨样结构的可行性来验证这一假设,该支架中接种了人间充质干细胞(hMSC)。将具有小(106-212μm)、中(212-300μm)和大孔径范围(300-425μm)的支架接种 hMSC,然后在体外分化为类似于初始支架几何形状的骨样组织,并具有骨样结构。植入小鼠颅骨缺损 8 周后,体外工程化的骨样组织已重塑为具有不同编织/板层骨比例的骨,桥接缺损。无论孔径如何,所有植入物都很好地整合在一起,血管化进展,骨髓内生长已经开始。最终,在这种缺陷模型中,体外生成的组织工程骨结构的几何形状,小梁状或板状,对缺陷的愈合没有显著影响,这是由于其在植入后的结构的有效重塑。